Chanan Morris - Net Worth and Insider Trading

Chanan Morris Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Chanan Morris owns 2 companies in total, including Artemis Therapeutics Inc (ATMS) , and Manuka Inc (MNKA) .

Click here to see the complete history of Chanan Morris’s form 4 insider trades.

Insider Ownership Summary of Chanan Morris

Ticker Comapny Transaction Date Type of Owner
ATMS Artemis Therapeutics Inc 2014-10-10 Chief Financial Officer
MNKA Manuka Inc 2014-10-10 Chief Financial Officer

Chanan Morris Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Chanan Morris Ownership Network

Ownership Network List of Chanan Morris

No Data

Ownership Network Relation of Chanan Morris

Insider Network Chart

Chanan Morris Owned Company Details

What does Artemis Therapeutics Inc do?

Who are the key executives at Artemis Therapeutics Inc?

Chanan Morris is the Chief Financial Officer of Artemis Therapeutics Inc. Other key executives at Artemis Therapeutics Inc include Chief Financial Officer David Dana , director & Chief Executive Officer Shimon Citron , and Chief Executive Officer Brian M Culley .

Artemis Therapeutics Inc (ATMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Artemis Therapeutics Inc (ATMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Artemis Therapeutics Inc (ATMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Artemis Therapeutics Inc (ATMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Artemis Therapeutics Inc Insider Transactions

No Available Data

Chanan Morris Mailing Address

Above is the net worth, insider trading, and ownership report for Chanan Morris. You might contact Chanan Morris via mailing address: 30 Haktoret Street, Efrat L3 90435.

Discussions on Chanan Morris

No discussions yet.